Latest Trials

EudraCT Number: 2004-001507-35 Sponsor Protocol Number: AZA PH GL 2003 CL 001 Start Date: 2005-03-07
Sponsor Name: Pharmion Corporation
Full Title: A Multicenter, Randomized, Open-Label, Parallel-Group, Phase 3 Trial of Subcutaneous Azacitidine Plus Best Supportive Care Versus Conventional Care Regimens Plus Best Supportive Care for the Treatm...
Medical condition: The myelodysplastic syndromes (MDS) are a group of potentially acute myeloid leukemic disorders. The disorders of myeloid origin include acute myeloid leukemia (AML), MDS and myeloproliferative dis...
Disease: Version SOC Term Classification Code Term Level
6.1 10028533 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-004868-69 Sponsor Protocol Number: AP7000_1-4002 Start Date: 2005-03-07
Sponsor Name: ZLB Behring LLC
Full Title: Study of Safety and Efficacy of Antihemophilic Factor / von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects with von Willebrand’s Disease
Medical condition: Von Willebrand’s disease (VWD) is a common hereditary bleeding disorder. The impaired formation and adhesion of the initial platelet plug is reflected in the prolonged skin bleeding time. In addit...
Disease: Version SOC Term Classification Code Term Level
7.1 10047715 LLT
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) SE (Completed)
Trial results: View results
EudraCT Number: 2004-004225-10 Sponsor Protocol Number: 3001081 Start Date: 2005-03-07
Sponsor Name: Orion Pharma
Full Title: Effects of peroral levosimendan in the prevention of further hospitalisations in patients with chronic heart failure. A randomised, double-blind, placebo-controlled, multi-centre, parallel-group study
Medical condition: Cardiac Failure
Disease: Version SOC Term Classification Code Term Level
7.1 10007554 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) LT (Completed) LV (Completed) EE (Completed)
Trial results: View results
EudraCT Number: 2004-004193-91 Sponsor Protocol Number: DPB100925 Start Date: 2005-03-07
Sponsor Name: GlaxoSmithKline Research & Development Ltd
Full Title: A 12-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy, Safety and Tolerability of GW823093 (2.5mg, 7.5mg, 15mg, 30mg and ...
Medical condition: Type 2 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
7.1 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) DE (Completed) SE (Completed) CZ (Completed) LV (Completed)
Trial results: View results
EudraCT Number: 2004-002677-24 Sponsor Protocol Number: self sponsored Start Date: 2005-03-07
Sponsor Name: Karolinska Institutet, Institutionen för klinisik neurovetenskap, sektion för psykiatri
Full Title: Hormonersättningseffekt på serotoninåterupptag hos ooforektomerade kvinnor
Medical condition: Bilateral oophorectomy and hysterectomy and a wish for hormonal replacement therapy afterwards.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: SE (Completed)
Trial results: View results
EudraCT Number: 2004-002550-56 Sponsor Protocol Number: D6160C00003 Start Date: 2005-03-04
Sponsor Name: AstraZeneca AB
Full Title: A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Glycaemic Effec...
Medical condition: Men or women diagnosed with type 2 diabetes and treated with diet alone or on treatment with a single oral anti diabetic agent or low doses of two agents, and with diabetic dyslipidaemia; ie low HD...
Disease: Version SOC Term Classification Code Term Level
7 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) FI (Completed) DE (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-004907-39 Sponsor Protocol Number: D0170C00009 Start Date: 2005-03-04
Sponsor Name: AstraZeneca AB
Full Title: A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo i...
Medical condition: Diagnostic of Post Traumatic Neuralgia
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-004559-21 Sponsor Protocol Number: CLAF237A2308 Start Date: 2005-03-04
Sponsor Name: Novartis Pharma Services AG
Full Title: A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Long-Term Effect (up to 5 Years) of Treatment with LAF237 50 mg bid to Glimepiride up to 6 mg Daily as Add-On Therapy...
Medical condition: Type II Diabetes
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) DK (Prematurely Ended) GB (Completed) LT (Completed) EE (Completed) LV (Completed) IT (Prematurely Ended) DE (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-004933-32 Sponsor Protocol Number: km 55/2004 – LORISTAH/CZ Start Date: 2005-03-04
Sponsor Name: KRKA, d. d., Novo mesto
Full Title: Efficacy and safety of Lorista and Lorista H in the treatment of mild to moderate arterial hypertension
Medical condition: mild to moderate hypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003734-34 Sponsor Protocol Number: BT0800BEL001 Start Date: 2005-03-03
Sponsor Name: Barrier Therapeutics nv
Full Title: A one-weel, randomized, double-blind, placebo-controlled pilot trial to evaluate oral R129160 (60 mg b.i.d.) on the alleviation of itch in atopic dermatitis patients
Medical condition: Atopic Dermatitis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: BE (Ongoing) CZ (Ongoing)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe